1.
Hu R, Chen X, Zhang S, Liu B, Pei H, Tu F, Liu J, Yu H. Plasma exosome-derived fragile site-associated tumor suppressor as a powerful prognostic predictor for patients with ovarian cancer. Bosn J of Basic Med Sci [Internet]. 2022Jun.1 [cited 2022Jul.5];22(3):453-9. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/6404